-
Orthovita Launches The Aliquot Directional Bone Tamp (VITA)
Wednesday, April 13, 2011 - 9:42am | 56Orthovita (NASDAQ: VITA) announced today the launch of the Aliquot Directional Bone Tamp. The Directional Bone Tamp, a channel creation device that allows safe and targeted placement of Cortoss Bone Augmentation Material into the vertebral body, expands the procedural options for Cortoss in the...
-
J.P. Morgan Reiterates Neutral on Wright Medical Group (WMGI)
Wednesday, April 13, 2011 - 9:00am | 137J.P. Morgan is out with its report on Wright Medical Group (NASDAQ: WMGI), reiterating Neutral. In a note to clients, J.P. Morgan writes, "The Wright business model has historically targeted 100-150bps of annual operating margin expansion, but with top-line growth in the low to mid single digits,...
-
Deutsche Bank Raises PT On DHR To $65
Wednesday, April 13, 2011 - 8:22am | 131Deutsche Bank has raised its price target on Danaher (NYSE: DHR) from $60 to $65 reflecting the company's acquisition of Beckman Coulter (NYSE: BEC), which is expected to happen by mid-May. Says Deutsche Bank, in its report, “DHR remains one of our favorite ideas given positive risk/reward vs. our...
-
Morgan Keegan Gives Earnings Preview On Hospital Supplies Industry
Wednesday, April 13, 2011 - 7:52am | 203Calendar first-quarter earnings for the hospital supplies group are scheduled to kick-off on April 19th. Going into earnings, Morgan Keegan's favorite long idea is Covidien (NYSE: COV) with the potential for EPS upside due to improving margins and positive commentary that surgical procedures growth...
-
Stryker Corp. Director Sells 27,000 Shares of SYK
Tuesday, April 12, 2011 - 4:37pm | 61In a Form 4 filed earlier today, Stryker Corp. (NYSE: SYK) Director, Ronda Stryker, reported that she sold 27,000 shares of SYK on April 8th-12th for an average price of $59.78. The transaction totaled $1,614,084. This sale was 10b5-1 Plan indicated. Mrs. Stryker owns 132,000 direct shares and 33...
-
Stryker Corp. Director Sells 27,000 Shares of SYK
Tuesday, April 12, 2011 - 4:36pm | 61In a Form 4 filed earlier today, Stryker Corp. (NYSE: SYK) Director, Ronda Stryker, reported that she sold 27,000 shares of SYK on April 8th-12th for an average price of $59.78. The transaction totaled $1,614,084. This sale was 10b5-1 Plan indicated. Mrs. Stryker owns 132,000 direct shares and 33...
-
Abiomed Hits 52-Week High (ABMD)
Tuesday, April 12, 2011 - 3:52pm | 32Abiomed (NASDAQ: ABMD) has hit a 52-week high in today's trading. At last check the year-to-date performance of Abiomed has been a gain of 68.9%.
-
Angeion's Medical Graphics Business Awarded National Group Purchasing Contract
Tuesday, April 12, 2011 - 2:02pm | 114Angeion Corporation (NASDAQ: ANGN) announced that it has been awarded a three-year contract with Premier Purchasing Partners L.P., the group-purchasing unit of Premier Inc. of Charlotte, NC and a leading performance improvement alliance for healthcare providers. The agreement is for Angeion's...
-
Options Brief: Stryker Corporation (SYK)
Tuesday, April 12, 2011 - 11:11am | 79Shares of Stryker Corporation (NYSE: SYK) are lower on the session by 0.98%, trading at $4.27. Overall put volume is now running at 4.27x the daily average, with 0% of all puts traded being purchases on the offer. 1,692 contracts have traded on the session so far. Stryker Corporation is a...
-
Puts Purchased on China North East Petroleum (NEP)
Tuesday, April 12, 2011 - 10:58am | 153Shares of China North East Petroleum (AMEX: NEP) are lower on the session by 7.62%, currently trading at $3.76. The stock has been moving largely lower over the past six months and is currently trading below the 50-day and 200-day moving averages. Options traders are buying puts on the name today...
-
Forest Laboratories Announces Successful Completion of Tender Offer for Securities of Clinical Data
Tuesday, April 12, 2011 - 9:29am | 105Forest Laboratories, Inc. (NYSE: FRX) today announced that its indirect wholly-owned subsidiary, Magnolia Acquisition Corp., has accepted for purchase all of the securities validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of, and...
-
JP Morgan Remains Positive On Hologic; Raises PT To $24
Tuesday, April 12, 2011 - 9:26am | 186Despite the appreciation in Hologic's (NASDAQ: HOLX) share price YTD, JP Morgan thinks that Hologic remains poised for additional upside based on several factors, including: ample early- adopter demand for Selenia Dimensions tomosynthesis, driving near-term results; and a continued rebound in...
-
Benzinga's Top Downgrades (MDVN, WMS, AMMD, AA)
Tuesday, April 12, 2011 - 8:20am | 137Medivation Inc (NASDAQ: MDVN) was downgraded by Roth Capital from "buy" to "neutral." MDVN's shares closed at $20.48 yesterday. Medivation's trailing-twelve-month ROE is -206.55%. Jefferies downgraded WMS Industries Inc (NYSE: WMS) from “buy” to “hold.” WMS' stock closed at $36.22 yesterday. WMS...
-
UPDATE: Oppenheimer Raises PT on Endo Pharmaceuticals to $48 (ENDP)
Tuesday, April 12, 2011 - 7:50am | 159Oppenheimer is out with its report today on Endo Pharmaceuticals (NASDAQ: ENDP), raising its PT from $42 to $48. In a note to clients, Oppenheimer writes, "On 4/11, ENDP announced the ~$2.9B all-cash acquisition of med device manufacturer American Medical Systems (NASDAQ: AMMD). Of note, ENDP's...
-
JP Morgan Raises PT On Hologic To $24
Tuesday, April 12, 2011 - 7:35am | 26JP Morgan has raised the price target on Hologic (NASDAQ: HOLX) from $21 to $24 and maintains its Overweight rating.